Easterly Investment Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$681K Hold
5,300
0.03% 209
2026
Q1
$638K Sell
5,300
-57,493
-92% -$6.64M 0.05% 130
2025
Q4
$6.61M Sell
62,793
-68,750
-52% -$6.45M 0.41% 64
2025
Q3
$11M Sell
131,543
-12,947
-9% -$1.07M 0.75% 41
2025
Q2
$11.4M Buy
144,490
+5,147
+4% +$409K 0.82% 39
2025
Q1
$12.5M Sell
139,343
-19,497
-12% -$1.82M 1.04% 26
2024
Q4
$15.8M Buy
158,840
+38,987
+33% +$4.02M 1.24% 15
2024
Q3
$13.6M Buy
119,853
+80,428
+204% +$9.56M 1.09% 23
2024
Q2
$4.88M Sell
39,425
-56,202
-59% -$7.24M 0.43% 71
2024
Q1
$12.6M Sell
95,627
-37,613
-28% -$4.64M 0.96% 32
2023
Q4
$14.5M Sell
133,240
-2,666
-2% -$277K 1.55% 14
2023
Q3
$14M Buy
135,906
+30,124
+28% +$3.25M 1.54% 11
2023
Q2
$12.2M Sell
105,782
-55,821
-35% -$6.34M 1.08% 33
2023
Q1
$17.2M Buy
161,603
+47,938
+42% +$5.18M 1.51% 16
2022
Q4
$12.6M Sell
113,665
-177,596
-61% -$18.2M 1.09% 34
2022
Q3
$25.1M Buy
291,261
+80,493
+38% +$7.19M 2.4% 4
2022
Q2
$19.2M Sell
210,768
-118,660
-36% -$10.5M 1.71% 12
2022
Q1
$27M Buy
329,428
+7,100
+2% +$560K 2.05% 9
2021
Q4
$24.7M Sell
322,328
-274,145
-46% -$21.8M 1.8% 9
2021
Q3
$44.8M Buy
596,473
+83,723
+16% +$6.37M 3.04% 2
2021
Q2
$39.9M Buy
512,750
+70,580
+16% +$5.25M 4.68% 1
2021
Q1
$32.5M Buy
442,170
+100,168
+29% +$7.39M 3.89% 2
2020
Q4
$26.7M Buy
+342,002
New +$26.2M 3.69% 9

Other funds holding MRK

Easterly Investment Partners's MRK Position: Q2 2026 in Review

Easterly Investment Partners held its Merck (MRK) position steady in Q2 2026 at 5,300 shares worth $681K. The position accounts for 0.03% of the portfolio, ranked #209.

Easterly Investment Partners first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $44.8M in Q3 2021. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Easterly Investment Partners held 5,300 shares of Merck worth $681K as of Q2 2026.
  • Easterly Investment Partners left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.03% of Easterly Investment Partners's portfolio in Q2 2026, its #209 holding.
  • Easterly Investment Partners first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • Easterly Investment Partners's Merck position peaked at $44.8M in Q3 2021.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Easterly Investment Partners's 13F filing for Q2 2026, filed 23 Jul 2026.